Annual Drug Patent Expirations for WELIREG Welireg is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There are two…
Source
Annual Drug Patent Expirations for ZONTIVITY Zontivity is a drug marketed by Xspire Pharma and is included in one NDA. There are two patents protecting this drug. ZONTIVITY drug price…
Source
New patent expiration for Xspire Pharma drug ZONTIVITY Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Estonia. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
Source
Which pharmaceutical companies have the most SPCs in Estonia? Read Post »
Annual Drug Patent Expirations for WELIREG Welireg is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There are two…
Source
Annual Drug Patent Expirations for ZONTIVITY Zontivity is a drug marketed by Xspire Pharma and is included in one NDA. There are two patents protecting this drug. ZONTIVITY drug price…
Source
New patent expiration for Xspire Pharma drug ZONTIVITY Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Estonia. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
Source
Which pharmaceutical companies have the most SPCs in Estonia? Read Post »
Annual Drug Patent Expirations for VOYDEYA Voydeya is a drug marketed by Alexion Pharms Inc and is included in one NDA. It is available from one supplier. The generic ingredient…
Source
Annual Drug Patent Expirations for BYFAVO Byfavo is a drug marketed by Acacia and is included in one NDA. It is available from one supplier. There are eleven patents protecting…
Source
Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
Source
Annual Drug Patent Expirations for INOMAX Inomax is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from one supplier. There are fifteen patents…
Source
Get new actionable insights and updates from BiotechBlog
